INHALABLE INSULIN FOR DIABETES SUFFERERS
Alexandria, VA -- November 4, 1999 -- Freedom from painful self-injections may be close to reality for the 16 million Americans who suffer from Type I and Type II diabetes. Researchers have developed a very stable formulation delivered by a spray that disperses insulin into the bloodstream through tissues in the mouth.
This is revolutionary for several reasons: 1) it doesn't need refrigeration like conventional insulin 2) it is inhaled through the mouth 3) it is tasteless. The device called pMDA(tm) is poised for human trials.
This topic and others will be presented at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting "Quest for the Magic Bullet: An Astounding Century." More than seven thousand pharmaceutical scientists from around the world will gather at the New Orleans meeting November 14-18, to share the latest scientific research.
AAPS is a professional, scientific society of more than 9,000 members employed in academia, industry, government and other research institutes worldwide. Founded in 1986, AAPS aims to advance science through the open exchange of scientific knowledge, serve as an information resource, and contribute to human health through pharmaceutical research and development. For more information about AAPS, visit AAPS Online at http://www.aaps.org.
* * *
Editor's Note: For more information on the above research or to set up interviews with researchers, please contact Hannah Elinson ([email protected]) or Marie Bertot ([email protected]) at 305-573-9955. Abstracts of data can be previewed in a fully-searchable database on AAPS Online (www.aaps.org) or for complete up-to-date meeting information, please check out the AAPS Newsroom at http://www.aaps.org/sciaffairs/news.html.
RSS